12 Month Price Forecast For AFYA
Distance to AFYA Price Forecasts
AFYA Price Momentum
๐ค Considering Afya (AFYA)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 5:42 PM UTC
AFYA Analyst Ratings & Price Targets
Based on our analysis of 8 Wall Street analysts, AFYA has a neutral consensus with a median price target of $19.03 (ranging from $13.96 to $24.87). The overall analyst rating is Hold (5.8/10). Currently trading at $16.60, the median forecast implies a 14.6% upside. This outlook is supported by 3 Buy, 3 Hold, and 3 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AFYA Analyst Consensus
AFYA Price Target Range
Latest AFYA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AFYA.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jan 31, 2025 | Citigroup | Leandro Bastos | Sell | Downgrade | $15.00 |
Jan 17, 2025 | JP Morgan | Marcelo Santos | Neutral | Maintains | $20.50 |
Dec 3, 2024 | Goldman Sachs | Gustavo Miele | Sell | Initiates | $16.00 |
Aug 30, 2024 | UBS | Andre Salles | Neutral | Initiates | $19.50 |
Jun 21, 2024 | Morgan Stanley | Mauricio Cepeda | Equal-Weight | Maintains | $19.00 |
Jan 22, 2024 | Morgan Stanley | Javier Martinez | Equal-Weight | Downgrade | $23.00 |
Nov 27, 2023 | JP Morgan | Marcelo Santos | Neutral | Downgrade | $23.00 |
Oct 13, 2023 | Morgan Stanley | Javier Martinez | Overweight | Upgrade | $20.50 |
Nov 22, 2022 | Credit Suisse | Mauricio Cepeda | Outperform | Maintains | $18.00 |
Aug 23, 2022 | Credit Suisse | Outperform | Upgrade | $0.00 | |
Apr 8, 2022 | Credit Suisse | Mauricio Cepeda | Outperform | Upgrade | $19.00 |
Mar 7, 2022 | UBS | Maria Tereza Azevedo | Buy | Maintains | $21.00 |
Jul 21, 2021 | Morgan Stanley | Javier Martinez | Equal-Weight | Downgrade | $28.50 |
Apr 15, 2021 | UBS | Buy | Upgrade | $0.00 | |
Feb 4, 2021 | JP Morgan | Overweight | Upgrade | $0.00 | |
Oct 19, 2020 | JP Morgan | Neutral | Downgrade | $0.00 | |
Sep 28, 2020 | Goldman Sachs | Buy | Upgrade | $0.00 | |
Aug 19, 2020 | Credit Suisse | Neutral | Initiates | $0.00 | |
May 20, 2020 | UBS | Neutral | Downgrade | $0.00 | |
May 5, 2020 | JP Morgan | Overweight | Maintains | $24.50 |
Stocks Similar to Afya Ltd
The following stocks are similar to Afya based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Afya Ltd (AFYA) Financial Data
Afya Ltd has a market capitalization of $1.51B with a P/E ratio of 15.1x. The company generates $530.58M in trailing twelve-month revenue with a 18.0% profit margin.
Revenue growth is +13.7% quarter-over-quarter, while maintaining an operating margin of +28.5% and return on equity of +15.3%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Afya Ltd (AFYA) Company Overview
About Afya Ltd
Provides medical education and digital health services.
The company generates revenue through offering a diverse range of educational products and services, including medical schools, residency courses, and health science programs. It also monetizes its digital health services through subscription models for its mobile app and online portal, which assist healthcare professionals and students with clinical decision-making.
Afya operates in three segments: Undergrad, Continuing Education, and Digital Services, and offers a variety of programs across multiple health and academic disciplines. The company also provides practice management software and various health-related digital solutions, expanding its reach in the healthcare sector. Founded in 1999 and headquartered in Brazil, Afya is well-positioned in the growing medical education market.
Company Information
Sector
Consumer Defensive
Industry
Education & Training Services
Employees
0
CEO
Country
Brazil
IPO Year
2019
Website
www.afya.com.brAfya Ltd (AFYA) Latest News & Analysis
Afya Limited has signed a share purchase agreement to acquire 100% of Faculdade Masterclass Ltda in Contagem, Brazil, through its subsidiary Afya Participaรงรตes S.A.
Afya's acquisition of Faculdade Masterclass expands its market presence and educational offerings in Brazil, potentially enhancing revenue growth and competitive positioning.
AFYA has entered into a share purchase agreement to acquire 100% of FUNIC.
AFYA's acquisition of FUNIC may enhance its market position, increase revenue streams, and improve growth prospects, potentially influencing stock performance and investor sentiment.
Afya reported 12% organic revenue growth and 16% overall growth in Q3 2024, boosted by the Unidom acquisition. Adjusted EBITDA margin rose by 300bps, with net income up 68% YoY. P/E is 11x.
Afya's strong revenue growth and improved margins indicate robust business performance. Attractive valuation and growth prospects enhance appeal for potential investment returns.
Afya Limited (Nasdaq: AFYA) reported its Q3 2024 financial results, with figures presented in Brazilian Reais and compliant with IFRS. Further details on performance are expected.
Afya Limited's Q3 2024 financial results indicate its performance trajectory, impacting investor sentiment and stock valuation in the medical education and practice solutions sector.
Afya (AFYA) Q3 Earnings Miss Estimates
2 months agoAfya (AFYA) reported Q3 earnings of $0.32 per share, below the Zacks estimate of $0.36. This marks an increase from $0.28 per share in the same period last year.
Afya's earnings miss raises concerns about growth potential and market performance, potentially impacting share prices and investor sentiment.
Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th
3 months agoAfya Limited will report its Q3 2024 financial results on November 13, 2024, after market close, followed by a conference call at 5 PM EST.
Afya Limited's upcoming financial results announcement on November 13, 2024, will provide insights into its performance and growth potential, influencing investor sentiment and stock valuation.
Frequently Asked Questions About AFYA Stock
What is Afya Ltd's (AFYA) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, Afya Ltd (AFYA) has a median price target of $19.03. The highest price target is $24.87 and the lowest is $13.96.
Is AFYA stock a good investment in 2025?
According to current analyst ratings, AFYA has 3 Buy ratings, 3 Hold ratings, and 3 Sell ratings. The stock is currently trading at $16.60. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for AFYA stock?
Wall Street analysts predict AFYA stock could reach $19.03 in the next 12 months. This represents a 14.6% increase from the current price of $16.60. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Afya Ltd's business model?
The company generates revenue through offering a diverse range of educational products and services, including medical schools, residency courses, and health science programs. It also monetizes its digital health services through subscription models for its mobile app and online portal, which assist healthcare professionals and students with clinical decision-making.
What is the highest forecasted price for AFYA Afya Ltd?
The highest price target for AFYA is $24.87 from at , which represents a 49.8% increase from the current price of $16.60.
What is the lowest forecasted price for AFYA Afya Ltd?
The lowest price target for AFYA is $13.96 from at , which represents a -15.9% decrease from the current price of $16.60.
What is the overall AFYA consensus from analysts for Afya Ltd?
The overall analyst consensus for AFYA is neutral. Out of 8 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 3 as Sell, with a median price target of $19.03.
How accurate are AFYA stock price projections?
Stock price projections, including those for Afya Ltd, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.